Trial · NCT07900178

Sustaining Health After an Intensive Weight-loss Pro-gramme

NCT07900178, Enrolling by invitation, Copenhagen University Hospital, Hvidovre

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Sustaining Health After an Intensive Weight-loss Pro-gramme. Trials, record NCT07900178. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07900178

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Sustaining Health After an Intensive Weight-loss Pro-gramme
NCT number: NCT07900178
Status: Enrolling by invitation
Enrollment: 150 participants, estimated
Lead sponsor: Copenhagen University Hospital, Hvidovre
Conditions: Obesity & Overweight, Weight Loss, Weight Management in Adult Patients With Obesity or Overweight
First posted: 2026-10-28
Last updated: 2026-10-28

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Weight change	Assessed at follow-up (at least 12 months after programme completion).	Change in weight from the final programme measurement (measured between 21 and 24 months) to follow-up-assessment
Primary	Proteomics and metabolomics related to weight-loss and weight-gain.	Assessed at follow-up (at least 12 months after programme completion).
Primary	Change in skeletal muscle mass	Assessed at follow-up (at least 12 months).	We will calculate mean changes in skeletal muscle mass measured by bioimpedance
Primary	Health related quality of life	Assessed at follow-up (at least 12 months after programme completion).	We will estimate health related quality of life using the short form survey questionnaire (SF36).
Secondary	Change in fat mass	Assessed at follow-up (at least 12 months after programme completion).	Change in fat mass measured by bioimpedance from programme completion to follow up visit.
Secondary	Waist circumference	Assessed at follow-up (at least 12 months after programme completion).	Waist circumference will be measured between lowest palpable rib and top of the hip.
Secondary	Lower body strength	Assessed at follow-up (at least 12 months after programme completion).	We will measure lower body strength with a 30-Seconds SST(19). The test will be performed by those of the patients who was tested at 21 months.
Secondary	Use of weight-loss medication	Assessed at follow-up (at least 12 months after programme completion).	We will calculate the percent of patients who continued weight-loss medication after cessation of the programme and evaluate the dosages they use.
Secondary	Changes in blood-pressure	Assessed at follow-up (at least 12 months after programme completion).	We will measure changes in blood-pressure from 21 months to follow-up.
Secondary	Changes in Hba1c	Assessed at follow-up (at least 12 months after programme completion).	We will measure changes in HbA1c from 21 months to follow-up and combine this with data on medication requirements.

1 to 10 of 11Source ClinicalTrials.gov

See all 11 registered outcomes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07900178

GET https://conductscience.org/api/trials/v1/NCT07900178/registered

API reference For AI assistants